![Christopher John Ong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher John Ong
No más puestos en curso
Historial de carrera de Christopher John Ong
Antiguos cargos conocidos de Christopher John Ong.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Fundador | 26/12/2003 | - |
Estadísticas
Internacional
Canadá | 2 |
Operativa
Founder | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher John Ong
- Experiencia